Advisory panel OKs Evista to reduce breast cancer risk

Stephen McGuire

July 25 2007

An FDA advisory panel voted to back Eli Lillys request to tell patients its osteoporosis treatment Evista (raloxifene) also helps ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.